InvestorsHub Logo
Followers 36
Posts 5775
Boards Moderated 0
Alias Born 02/20/2015

Re: None

Wednesday, 05/23/2018 10:23:03 AM

Wednesday, May 23, 2018 10:23:03 AM

Post# of 50157
Shhhhhh. It's all starting to come together...


Delcath Announces Commercial Supply Agreement for Melphalan Hydrochloride for Injection with Tillomed Laboratories

“We are particularly pleased to be working with a supplier of Tillomed’s caliber and experience as it establishes firm control over our melphalan supply chain in Europe and, over time, will provide economies of scale", noted Jennifer K. Simpson, Ph.D., MSN, CRNP President and CEO of Delcath.

ECONOMIES OF SCALE: A proportionate saving in costs gained by an increased level of production.

Read: Additional supply is needed to match the increased demand for the CHEMSAT therapy.


http://delcath.com/investors-news/

Sam-approval in less than 1 year. Let's see what Right to Try brings >:-o

RDR, don't send a PM and then block my response. Don't worry, I am right and so I'll be back on full time soon enough.

Can you all see what's cooking?

"Giddy Up!"
-Kramer, CEO, Kramerika Industries
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News